22nd Century Group Applauds Califf Nomination as FDA Commissioner
November 15, 2021 09:20 ET
|
22nd Century Group, Inc
Califf Is a Longtime Proponent of Tobacco Control; Indicated Nicotine Mandate Should Be Key Priority For FDAMRTP Authorization And Launch of VLN® Will Serve as Vanguard for FDA’s Proposed Nicotine Cap...
22nd Century Group VP of Regulatory Science to Participate in FDLI Panel in Response to Recent FDA Action on Comprehensive Plan and Reduced Nicotine Mandate
October 13, 2021 16:01 ET
|
22nd Century Group, Inc
Company Supports This Week’s Positive FDA Action on E-Cigarettes, Demonstrating the Agency’s Commitment to Providing Adult Smokers with Alternatives to Highly Addictive CigarettesApplauds FDA’s Active...
22nd Century Group to Ring Nasdaq Closing Bell Today, August 16
August 16, 2021 09:20 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (formerly NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm...
22nd Century Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise
June 07, 2021 10:42 ET
|
22nd Century Group, Inc
Close Partnership With Aurora Cannabis Inc. to Enforce Shared Global Biosynthesis IP Rights Against Infringement and Actively Explore Commercial Development Opportunities; Monetization of Key Patented...
Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry
March 19, 2021 13:00 ET
|
22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...
22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants
March 12, 2021 10:00 ET
|
22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 12, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
March 11, 2021 07:00 ET
|
22nd Century Group, Inc
Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry.Securing Modified...
22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants
March 04, 2021 09:15 ET
|
22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...
DEADLINE FRIDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against 22nd Century Group, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
March 21, 2019 12:20 ET
|
Schall Law
LOS ANGELES, March 21, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against 22nd Century Group, Inc....
Pawar Law Group Announces a Securities Class Action Lawsuit Against 22nd Century Group, Inc. – XXII
March 20, 2019 21:28 ET
|
Pawar Law Group
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of 22nd Century Group, Inc. (NYSE:...